​

Funding Round

Series G - Epic Sciences

Series G - Epic Sciences

Investment Firm

Overview

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Announced Date

Apr 14, 2023

Closed on Date

Apr 14, 2023

Funding Type

Series G

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Arsenal Capital Partners

Arsenal Capital Partners

Arsenal Capital Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

3

Investor Name
Participant InvestorLabCorp
Participant InvestorArsenal Capital Partners
Participant InvestorDomain Associates

Round Details and Background

Epic Sciences raised $24000000 on 2023-04-14 in Series G

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 30, 2009
Series A - Epic Sciences
1-2.5M
Jun 01, 2015
Debt Financing - Epic Sciences
1-15.0M
Jul 30, 2014
Series C - Epic Sciences
5-30.0M
Nov 13, 2012
Series B - Epic Sciences
3-13.0M

Recent Activity

There is no recent news or activity for this profile.